Access to high-quality medicines in low- and middle-income countries (LMICs), particularly in Sub-Saharan Africa (SSA), is impeded by medical supply chain issues such as substandard or counterfeit medicines, limited affordability, and shortages. According to the World Health Organization, one in ten medicines in LMICs are of substandard quality or falsified and 70% of those circulate in Africa alone, leading to poor health outcomes, morbidity, and preventable deaths. The increasing adoption of digital technology in SSA provides opportunities to address this and transform healthcare.
Leveraging this opportunity, PharmAccess and Christian Health Association of Ghana (CHAG) created Med4All, a digital supply chain platform that consolidates online medication requests from healthcare providers and negotiates better prices from pre-approved suppliers based on the quantity of medication required. The platform aims to address challenges in Ghana’s medical supply chain, where fake drugs make up an estimated 30% of the market. Med4All ensures the quality and authenticity of medications supplied via the platform through collaboration with Ghana’s Food and Drug Authority (FDA).
Med4All ensures the availability of affordable and reliable medications, particularly for non-communicable diseases (NCDs), to prevent long-term health complications. This is crucial since NCDs have become the leading cause of morbidity and mortality in Ghana.
